SEATTLE, Sept. 14, 2018 /PRNewswire/ — Bruker today announced the introduction of the new preclinical PET/CT Si78 scanner for whole-body molecular imaging at the World Molecular Imaging Congress (www.wmis.org/2018-wmic). It combines Bruker’s novel PET and outstanding micro-CT technologies in a single scanner operated by the multi-modality imaging software platform ParaVision™ 360. The PET/CT Si78 is addressing... Read more
SEATTLE, Sept. 14, 2018 /PRNewswire/ — Bruker today announced the introduction of the new preclinical PET/CT Si78 scanner for whole-body molecular imaging at the World Molecular Imaging Congress (www.wmis.org/2018-wmic). It combines Bruker’s novel PET and outstanding micro-CT technologies in a single scanner operated by the multi-modality imaging software platform ParaVision™ 360. The PET/CT Si78 is addressing... Read more
Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.–(BUSINESS WIRE)–Sep. 12, 2018– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination... Read more
September 11, 2018 Cambridge, Mass. and Athens, Greece., Sept 11, 2018. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine... Read more
September 10, 2018 Cambridge, Mass. Sept 10, 2018. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource... Read more
Walkersville, MD (USA)/Basel (CH), 3 September 2018 – Lonza will reveal its next-generation endotoxin automation solution, PyroTec™ Pro Robotic Solution at the Parenteral Drug Association (PDA) Global Conference on Pharmaceutical Microbiology from 15-16 October, in Bethesda, MD (USA). At Booth #308 Lonza experts will demonstrate how the company’s instruments, reagents and software are integrated into... Read more
BEIJING, Sept. 3, 2018 /PRNewswire/ — On August 29, 2018, Mr. Joydeep Goswami, the President of Clinical NGS and Oncology Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher), and Mr. Peter Vuong, the Director of Global Product Management, Clinical NGS division Thermo Fisher visited the Beijing headquarters of Genetron Health, conducted in-depth discussions on strategic... Read more
(ANN ARBOR, Mich. – Aug. 28, 2018 ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift’s targeted NGS portfolio facilitates the detection and validation of mutations occurring at... Read more
Facility Will Enhance Enzo’s Ability to Produce and Distribute Its Growing Portfolio of Molecular Assays, Immunohistochemistry, Immunoassays and Immuno-oncology Products and Services Anticipates Significant Tax and Other Incentives for Enzo’s Entire Farmingdale New York Campus August 27, 2018 05:30 AM Pacific Daylight Time NEW YORK–(BUSINESS WIRE)–Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company,... Read more
— Bruker’s MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections — Acquisition to expand Bruker’s presence in attractive microbiology and virology infectious disease MDx markets, in support of Bruker’s portfolio transformation — Hain to add expertise in tuberculosis and mycobacteria... Read more